Does EZETIMIBE Cause Peripheral arterial occlusive disease? 49 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Peripheral arterial occlusive disease have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.4% of all adverse event reports for EZETIMIBE.
49
Reports of Peripheral arterial occlusive disease with EZETIMIBE
0.4%
of all EZETIMIBE reports
0
Deaths
24
Hospitalizations
How Dangerous Is Peripheral arterial occlusive disease From EZETIMIBE?
Of the 49 reports, 24 (49.0%) required hospitalization.
Is Peripheral arterial occlusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Peripheral arterial occlusive disease?
NILOTINIB (319)
METHOTREXATE (120)
ADALIMUMAB (116)
RIVAROXABAN (101)
PONATINIB (90)
IMATINIB (86)
ASPIRIN (77)
ATORVASTATIN (70)
METOPROLOL (70)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)
Which EZETIMIBE Alternatives Have Lower Peripheral arterial occlusive disease Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI